Fresh analysis reveals that patients who stop using blockbuster slimming jabs like Wegovy and Mounjaro tend to recover shed pounds at a significantly accelerated pace than those who end conventional lifestyle regimens.
Published data in a major health publication shows that while obese people frequently drop a large proportion of their body weight while using the jabs, the mass comes back at an estimated rate of nearly a kilo each month once they quit.
"Users purchasing such drugs need to be informed of the potential of rapid weight regain when the therapy is stopped," cautioned lead investigator Dr. Susan Jebb.
That rate of recovery implies a reversion to pre-treatment mass in about a year and a half.
Analyzing Treatments
The analysis, which looked at 37 of studies involving over 9,000 of participants, compared the outcomes of GLP-1 agonists with other pills.
Researchers note that individuals who shed pounds through diet and exercise typically see a less rapid creep back—approximately 100 grams monthly—post-intervention.
Understanding the Quick Rebound
Experts believe the way of the injections accounts for the accelerated regain.
These medications copy a body's own chemical called glucagon-like peptide-1, which moderates appetite.
"Artificially providing the hormone levels several times higher than the body's typical production might result in the system to produce less of its endogenous GLP-1, and may also reduce sensitivity to its effects," noted Dr. Adam Collins, a dietetics expert.
"Withdrawal of this medication means appetite is unsuppressed, making binge eating a significant risk."
A Lifelong Issue?
The NHS recommend the injections for people with obesity-related health risks, accompanied by prescribed lifestyle changes.
Many experts contend that, considering the likelihood of relapse, the treatment might need to be life-long.
This perspective is reinforced by pharmaceutical companies, who note that the results "underscore the persistent nature of excess weight," akin to managing diseases like high blood pressure.
User Experiences
Users who have discontinued the jabs describe a intense return of hunger.
"I experienced a trigger that goes on and you're instantly ravenous," described a patient.
The struggle is compounded if patients have not developed sustainable dietary or behavioural modifications during treatment.
Widespread Adoption
Survey data suggest that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with desire being substantial.
- Use is greater among women than males.
- The middle-aged age group shows the highest usage rates.
- A large proportion obtain the drugs through private prescriptions rather than public health services.
In conclusion, experts emphasize that while these medications are potent agents for shedding pounds, they are not a magic fix and lasting health benefits relies on combined behavioural support.
